(Q28577768)

31 January 2017

title

Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro (English)

1 reference

31 January 2017

Li Sheng

1

1 reference

31 January 2017

Ping Ye

2

1 reference

31 January 2017

Yong-Xue Liu

3

1 reference

31 January 2017

Chun-Guang Han

4

1 reference

31 January 2017

Zhi-Yi Zhang

5

1 reference

31 January 2017

publication date

1 February 2008

1 reference

Clinical and Experimental Hypertension

31 January 2017

published in

1 reference

31 January 2017

volume

30

1 reference

31 January 2017

issue

2

1 reference

31 January 2017

page(s)

109–119

1 reference

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/10641960801945840

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10641960801945840

Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10641960801945840

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/10641960801945840

Medical significance of peroxisome proliferator-activated receptors.

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

TGF-beta1 and angiotensin networking in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960801945840

10.1080/10641960801945840

21 January 2018

Identifiers

DOI

1 reference

31 January 2017

1 reference